Modulation of the inflammatory response in cardiovascular disease

Area of Science:

• Cardiovascular Science
• Inflammation Research
• Pathophysiology of Atherosclerosis

Background:

• Cardiovascular diseases (CVDs) are increasingly recognized as chronic inflammatory conditions.
• Risk factors for CVD induce an inflammatory phenotype in endothelial cells, characterized by oxidative stress and leukocyte adhesion.
• Initial research focused on oxidative stress and adhesion molecules, but other factors are now implicated.

Purpose of the Study:

• To explore the role of inflammation in the initiation and progression of cardiovascular diseases (CVDs).
• To investigate additional factors beyond oxidative stress that modulate inflammatory responses in CVD.
• To identify potential therapeutic targets by understanding the integration of inflammation and coagulation in CVD.

Main Methods:

• Review of current scientific literature on inflammation and cardiovascular disease.
• Analysis of mechanisms linking endothelial cell activation, oxidative stress, and leukocyte adhesion.
• Examination of the role of platelets, angiotensin II, and CD40/CD40 ligand signaling in CVD pathogenesis.

Main Results:

• Endothelial cells in CVD exhibit an inflammatory phenotype with oxidative stress and increased leukocyte adhesion.
• Platelets, angiotensin II, and the CD40/CD40 ligand system are emerging as key contributors to CVD pathogenesis.
• These factors converge with oxidative stress pathways, explaining the link between coagulation and inflammation in CVD.

Conclusions:

• Inflammation is a critical component in the development and progression of cardiovascular diseases.
• Emerging factors provide novel insights into CVD pathogenesis and suggest multiple avenues for therapeutic intervention.
• Targeting these inflammatory pathways holds promise for effective CVD treatment.